Literature DB >> 21843266

Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation.

Jamak Modaresi Esfeh1, Bijan Eghtesad, Peter Hodgkinson, Teresa Diago, Masato Fujiki, Koji Hashimoto, Cristiano Quintini, Federico Aucejo, Dympna Kelly, Charles Winans, David Vogt, Charles Miller, Nizar Zein, John Fung.   

Abstract

BACKGROUND: Reconstruction of biliary drainage after liver transplantation (LTx) in patients with primary sclerosing cholangitis (PSC) has been a matter of controversy. Over recent years, the traditional method of Roux-en-Y hepaticojejunostomy (RY) has been challenged by duct-to-duct (DD) biliary reconstruction.
METHODS: This study represents a retrospective review of biliary complications, patient and graft survival after LTx in PSC patients based on type of biliary reconstruction. Outcomes of DD reconstruction in this group of patients and non-PSC patients are compared.
RESULTS: A total of 53 primary LTx procedures were performed for PSC between August 2005 and July 2010. Seven patients were excluded because unexpected cholangiocarcinoma was found in the explants (n=3) or because they received partial livers (n=4). Biliary reconstruction was performed as DD in 18 patients and RY in 28 patients. There were no bile leaks. Anastomotic stricture occurred in two (11%) patients in the DD group and one (4%) in the RY group. Two (7%) patients in the RY group developed non-PSC intrahepatic strictures and one had recurrence of PSC. Rates of 1- and 3-year patient and graft survival in the RY and DD groups were 96.7% and 96.7%, and 100% and 94.5%, respectively. In a group of 34 randomly selected patients transplanted for a non-PSC diagnosis with DD reconstruction during the same period, the anastomotic stricture rate was 9% and 1- and 3-year patient and graft survival rates were 97.0% and 88.5%; differences were not significant.
CONCLUSIONS: Duct-to-duct biliary reconstruction at the time of LTx in selected PSC patients is both effective and safe, and shows outcomes comparable with those of RY reconstruction in these patients and those of DD reconstruction in non-PSC patients.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21843266      PMCID: PMC3183450          DOI: 10.1111/j.1477-2574.2011.00346.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  30 in total

1.  Duct-to-duct biliary anastomosis for patients with sclerosing cholangitis undergoing liver transplantation.

Authors:  T G Heffron; G A Smallwood; T Ramcharan; L Davis; K Connor; E Martinez; A C Stieber
Journal:  Transplant Proc       Date:  2003-12       Impact factor: 1.066

2.  Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.

Authors:  Alonso Vera; Shazma Moledina; Bridget Gunson; Stefan Hubscher; Darius Mirza; Simon Olliff; James Neuberger
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

3.  Dominant strictures in patients with primary sclerosing cholangitis.

Authors:  Einar Björnsson; Joachim Lindqvist-Ottosson; Mats Asztely; Rolf Olsson
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

4.  Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  K A Fleming; K M Boberg; H Glaumann; A Bergquist; D Smith; O P Clausen
Journal:  J Hepatol       Date:  2001-03       Impact factor: 25.083

5.  Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.

Authors:  M Kaya; B T Petersen; P Angulo; T H Baron; J C Andrews; C J Gostout; K D Lindor
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

6.  Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.

Authors:  S Linder; C Söderlund
Journal:  Hepatogastroenterology       Date:  2001 Mar-Apr

Review 7.  Liver transplantation for primary sclerosing cholangitis.

Authors:  P J Gow; R W Chapman
Journal:  Liver       Date:  2000-04

Review 8.  Primary sclerosing cholangitis.

Authors:  Tom H Karlsen; Erik Schrumpf; Kirsten Muri Boberg
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

9.  High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.

Authors:  B Xu; U Broome; B-G Ericzon; S Sumitran-Holgersson
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 10.  Recurrence of primary sclerosing cholangitis after liver transplantation.

Authors:  Ivo W Graziadei
Journal:  Liver Transpl       Date:  2002-07       Impact factor: 5.799

View more
  2 in total

Review 1.  End-to-end ductal anastomosis in biliary reconstruction: indications and limitations.

Authors:  Beata Jabłonska
Journal:  Can J Surg       Date:  2014-08       Impact factor: 2.089

2.  Duct-to-Duct Biliary Anastomosis Yields Similar Outcomes to Roux-en-Y Hepaticojejunostomy in Liver Transplantation for Primary Sclerosing Cholangitis.

Authors:  Bandar Al-Judaibi; Roberto Hernandez Alejandro; Julia Uhanova; Paul Marotta; Mahmoud Mosli; Natasha Chandok
Journal:  Hepat Mon       Date:  2015-05-23       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.